tiprankstipranks
Trending News
More News >
Unicycive Therapeutics (UNCY)
NASDAQ:UNCY
US Market

Unicycive Therapeutics (UNCY) Financial Statements

Compare
754 Followers

Unicycive Therapeutics Financial Overview

Unicycive Therapeutics's market cap is currently $131.53M. The company's EPS TTM is $-0.33; its P/E ratio is -1.88; Unicycive Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 675.00K$ 951.00K$ 0.00$ 0.00
Gross Profit$ 0.00$ 675.00K$ 951.00K$ 0.00$ 0.00
Operating Income$ -32.12M$ -20.77M$ -18.05M$ -8.98M$ -2.02M
EBITDA$ -36.23M$ -30.18M$ -17.89M$ -9.38M$ 0.00
Net Income$ -36.73M$ -30.54M$ -18.06M$ -10.02M$ -2.51M
Balance Sheet
Cash & Short-Term Investments$ 26.14M$ 9.70M$ 455.00K$ 16.58M$ 0.00
Total Assets$ 31.67M$ 14.19M$ 2.82M$ 18.74M$ 204.00K
Total Debt$ 773.00K$ 811.00K$ 201.00K$ 335.00K$ 2.51M
Net Debt$ -25.37M$ -8.89M$ -254.00K$ -16.24M$ 2.51M
Total Liabilities$ 24.24M$ 18.00M$ 3.28M$ 2.26M$ 2.88M
Stockholders' Equity$ 7.43M$ -3.81M$ -466.00K$ 16.48M$ -2.67M
Cash Flow
Free Cash Flow$ -28.65M$ -18.30M$ -15.65M$ -5.80M$ -1.46M
Operating Cash Flow$ -28.57M$ -18.28M$ -15.65M$ -5.77M$ -1.46M
Investing Cash Flow$ -72.00K$ -12.00K$ -2.00K$ -29.00K$ 0.00
Financing Cash Flow$ 45.09M$ 27.54M$ -471.00K$ 22.38M$ 1.44M
Currency in USD

Unicycive Therapeutics Earnings and Revenue History

Unicycive Therapeutics Debt to Assets

Unicycive Therapeutics Cash Flow

Unicycive Therapeutics Forecast EPS vs Actual EPS